CreditReports.dk
HomeScreen companies

PHARMA MEDICO ApS Financials, key figures and credit report

CVR number: 28665741 Established 2006 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Hans Hartvig Seedorffs Stræde 12, 8000 Aarhus C www.pharmamedico.com
Gross profit 32 265.7 kDKK FY 2025 +49.5% vs 2024
EBIT 20 270.2 kDKK FY 2025 +93.6% vs 2024
Net debt -28 653.5 kDKK FY 2025 -8.1% vs 2024
Quick ratio 5.0 FY 2025 -1.8 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit21 547.8530 054.4226 192.9421 583.9932 265.73
Employee benefit expenses-9 008.60-7 802.10-7 993.34-7 920.02-8 961.41
Other operating expenses- 149.00- 325.00-71.75
Total depreciation- 449.51- 493.99- 982.25-2 867.89-2 962.40
EBIT11 940.7421 758.3217 217.3610 471.0920 270.17
Other financial income1 049.0733.55945.64993.07393.52
Other financial expenses- 329.94- 769.08- 130.06- 244.08- 734.52
Pre-tax profit12 659.8721 022.8018 032.9511 220.0819 929.17
Income taxes-2 277.14-4 584.75-4 014.32-2 611.11-4 521.44
Net earnings10 382.7316 438.0514 018.638 608.9715 407.74

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure4 267.669 932.5911 515.789 340.526 895.76
Intangible assets total4 267.669 932.5911 515.789 340.526 895.76
Buildings575.69339.151 597.021 235.07
Machinery and equipment626.77500.77733.71572.28678.01
Tangible assets total1 202.46839.92733.712 169.291 913.08
Investments total
Non-current other receivables1 252.451 252.45
Long term receivables total1 252.451 252.45
Finished products/goods3 125.883 396.223 017.283 427.334 154.80
Inventories total3 125.883 396.223 017.283 427.334 154.80
Current trade debtors18 253.2928 457.3719 130.2426 026.0425 899.02
Current amounts owed by group member comp.6 921.348 175.337 297.038 046.475 194.86
Prepayments and accrued income731.74833.45826.6333.19166.10
Current other receivables1 968.512 286.182 770.462 215.152 382.88
Short term receivables total27 874.8839 752.3330 024.3636 320.8533 642.86
Cash and bank deposits11 745.359 845.4926 666.4426 787.1231 100.47
Cash and cash equivalents11 745.359 845.4926 666.4426 787.1231 100.47
Balance sheet total (assets)48 216.2363 766.5571 957.5779 297.5578 959.41

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital126.25126.25126.25126.25126.25
Shares repurchased4 500.006 000.0020 000.00
Other reserves3 328.777 747.422 982.317 285.60-14 621.31
Retained earnings21 235.0627 199.1536 402.3052 117.6442 633.52
Profit of the financial year10 382.7316 438.0514 018.638 608.9715 407.74
Shareholders equity total39 572.8151 510.8659 529.4968 138.4663 546.19
Provisions845.302 125.002 444.001 979.001 427.00
Non-current liabilities total
Current loans from credit institutions294.94158.76171.35121.40
Advances received1 104.32
Current trade creditors5 631.506 060.364 939.935 735.159 624.73
Current owed to participating4.8034.5725.8323.7543.83
Current owed to group member80.652 281.72
Short-term deferred tax liabilities708.842 465.152 922.052 186.11163.44
Other non-interest bearing current liabilities1 116.601 275.671 937.52983.08646.79
Accruals and deferred income336.37
Current liabilities total7 798.1110 130.699 984.089 180.0913 986.22
Balance sheet total (liabilities)48 216.2363 766.5571 957.5779 297.5578 959.41
Page generated